Daylogue Expands Its Clinical Advisory Board as Wellness Apps Face New Scrutiny
As regulators and researchers push for more accountability in consumer mental wellness technology, Daylogue is adding clinical voices to its oversight structure — and publishing the list.
LOS ANGELES, CA, February 11, 2027 / PRNewswire / — Daylogue today announced the expansion of its Clinical Advisory Board, adding licensed clinicians, researchers, and public health professionals to the team that reviews the app's crisis detection architecture, privacy map, and content policy.
The board members are named. The scope of their role is published. The meeting cadence is disclosed. In a product category where "clinical advisory board" has become a marketing phrase with no standard definition, Daylogue is specifying exactly what its board reviews, how often, and what authority they hold over product decisions.
The board's responsibilities include quarterly review of the app's three-tier crisis detection architecture, oversight of the privacy policy as it applies to sensitive emotional data, and input on any feature that could affect a user who is in an acute period of distress. Board members are not asked to validate claims about clinical efficacy. They are asked to flag when the product is operating outside its appropriate lane.
"An advisory board that isn't named, with a role that isn't defined, is a press release," said Brandon Bibbins, Founder and CEO of Daylogue. "We want ours to be a function."
The expansion comes as consumer mental wellness apps face increasing scrutiny from researchers, regulators, and journalists examining how emotional data is handled, what crisis response looks like in practice, and whether apps that market to people in distress are living up to the responsibility that comes with that access. Daylogue's response is structural: put the oversight on paper, put the people's names next to it, and publish both.
The full board roster, each member's institutional affiliation, and the published scope of their role are available at daylogue.io/clinical-advisory.
"An advisory board that isn't named, with a role that isn't defined, is a press release. We want ours to be a function." — Brandon Bibbins, Founder and CEO, Daylogue
Frequently Asked Questions
Q: What does Daylogue's Clinical Advisory Board actually review?
The board reviews the app's crisis detection architecture, privacy policy as it applies to sensitive emotional data, and any product feature that touches users in potential distress. Meetings happen quarterly at minimum. Board scope is published on the Daylogue website and updated when the role changes.
Q: Does clinical advisory board membership mean Daylogue is clinically validated?
No. Daylogue is a wellness app, not a clinical tool. Board membership is an oversight function, not an endorsement of clinical efficacy. The board's job is to ensure the product stays within its appropriate scope — not to certify medical benefit.
Q: Why publish the scope of the board's role?
Because "advisory board" without a definition means nothing. Publishing the scope creates accountability in both directions: Daylogue is on record about what the board does, and the board members are on record about what they've agreed to review. Both parties can be held to what's written.
Q: Is this related to new regulation of wellness apps?
The expansion precedes any specific regulatory requirement. Daylogue is treating this as a proactive structural commitment. If regulation comes — and the trend in digital mental health suggests it will — the oversight structure is already in place.
About Daylogue
Daylogue is a pattern journal that reads your past entries and detects the emotional patterns running through them. Instead of a stack of separate journal entries, you get a short, plain-language summary that updates over time: what topics keep coming back, when a pattern is repeating, what's shifted in the last few weeks. Daylogue is not therapy and is not a replacement for professional care. It is a private space on your phone for honest reflection, a companion to therapy, to hard conversations, and to the days when you want to know yourself a little better. Entries written inside the Daylogue app are end-to-end encrypted on your device before upload, so Daylogue cannot read them. (SMS and email check-ins, and AI-generated summaries, are handled on the server and are not end-to-end encrypted. See Daylogue's privacy page for the full map.) Founded by Brandon Bibbins, Daylogue is independent and available on iOS and web at daylogue.io.
Media Contact
Daylogue hello@daylogue.io daylogue.io
SOURCE Daylogue